Anoro Ellipta (umeclidinium/vilanterol) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). Anoro Ellipta can interact with ...
Its biggest competitor is GSK, which also has a new dual bronchodilator Anoro Ellipta ... in a single once-daily dose in GSK’s Ellipta dry powder inhaler. Novartis says its results support ...
Having begun working together in December 2015, the partners are now ready to bring to market their custom digital sensor for GSK’s asthma and COPD inhaler, Ellipta. The sensor attaches to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback